Agree about the multiple of current SP.
One would of thought a equal ratio of progress in science eqatiting to SP rise.
Unless the selling reserves, it might simply be the case of overnight success...To which i have no dought the success will come....Possibly sooner than later, going on AML trail and hopefully results in both the breast and ovarian cancer trails.
For, PTX-200 involved in all three concurrent trails has synergy, low toxicity and high efficacy...
In science, these three parameters are vital, when one drug exhibits these and at different targets, then it gets noticed.
Luck to holders.
PTX Price at posting:
9.0¢ Sentiment: Buy Disclosure: Held
